4 research outputs found
The Interaction of CD97/ADGRE5 With β-Catenin in Adherens Junctions Is Lost During Colorectal Carcinogenesis
The adhesion G-protein-coupled receptor CD97/ADGRE5 is present in adherens junctions of human normal intestinal cells and upregulated in colorectal carcinomas. Here, we examined whether CD97 directly interacts with junctional proteins in normal and malignant colorectal tissue. We identified an association of CD97 with β-catenin using a proximity ligation assay and confirmed the interaction between both endogenous proteins at the biochemical level by co-immunoprecipitation in human and mouse tissues and cell lines. Glutathione S-transferase-pulldown revealed that CD97 binds β-catenin through its seven-span transmembrane/intracellular domain(s). To study tumor-associated changes in the interaction of CD97 and β-catenin in situ, we quantified and correlated both proteins at the membrane, and in the cytoplasm and nuclei of colorectal carcinomas and their corresponding normal tissues (n = 111). In normal colon, membranous levels of CD97 and β-catenin correlated strongly (p < 0.0001). To some degree both molecules disappeared in carcinomas simultaneously from the membrane of tumor cells (p = 0.017). CD97 accumulated in the cytoplasm, whereas β-catenin emerged in the cytoplasm and nuclei. CD97 and β-catenin levels in the cytoplasm correlated well (p < 0.0001). Irrespective of their subcellular localization, interaction of CD97 with β-catenin in tumor cells was also restricted to the cell contacts. Accordingly, CD97 did not regulate β-catenin-dependent TCF-mediated transcriptional activity. In summary, while CD97 and β-catenin interact in adherens junctions, their interaction is lost and both molecules follow different functional paths inside tumor cells
The Interaction of CD97/ADGRE5 With β-Catenin in Adherens Junctions Is Lost During Colorectal Carcinogenesis
The adhesion G-protein-coupled receptor CD97/ADGRE5 is present in adherens junctions
of human normal intestinal cells and upregulated in colorectal carcinomas. Here,
we examined whether CD97 directly interacts with junctional proteins in normal and
malignant colorectal tissue. We identified an association of CD97 with β-catenin using a
proximity ligation assay and confirmed the interaction between both endogenous proteins
at the biochemical level by co-immunoprecipitation in human and mouse tissues
and cell lines. Glutathione S-transferase-pulldown revealed that CD97 binds β-catenin
through its seven-span transmembrane/intracellular domain(s). To study tumor-associated
changes in the interaction of CD97 and β-catenin in situ, we quantified and
correlated both proteins at the membrane, and in the cytoplasm and nuclei of colorectal
carcinomas and their corresponding normal tissues (n = 111). In normal colon, membranous
levels of CD97 and β-catenin correlated strongly (p < 0.0001). To some degree
both molecules disappeared in carcinomas simultaneously from the membrane of tumor
cells (p = 0.017). CD97 accumulated in the cytoplasm, whereas β-catenin emerged
in the cytoplasm and nuclei. CD97 and β-catenin levels in the cytoplasm correlated
well (p < 0.0001). Irrespective of their subcellular localization, interaction of CD97 with
β-catenin in tumor cells was also restricted to the cell contacts. Accordingly, CD97 did
not regulate β-catenin-dependent TCF-mediated transcriptional activity. In summary,
while CD97 and β-catenin interact in adherens junctions, their interaction is lost and
both molecules follow different functional paths inside tumor cells
Mice overexpressing CD97 in intestinal epithelial cells provide a unique model for mammalian postnatal intestinal cylindrical growth
Postnatal enlargement of the mammalian intestine comprises cylindrical and luminal growth, associated with crypt fission and crypt/villus hyperplasia, respectively, which subsequently predominate before and after weaning. The bipartite adhesion G protein-coupled receptor CD97 shows an expression gradient along the crypt-villus axis in the normal human intestine. We here report that transgenic mice overexpressing CD97 in intestinal epithelial cells develop an upper megaintestine. Intestinal enlargement involves an increase in length and diameter but does not affect microscopic morphology, as typical for cylindrical growth. The megaintestine is acquired after birth and before weaning, independent of the genotype of the mother, excluding altered availability of milk constituents as driving factor. CD97 overexpression does not regulate intestinal growth factors, stem cell markers, and Wnt signaling, which contribute to epithelial differentiation and renewal, nor does it affect suckling-to-weaning transition. Consistent with augmented cylindrical growth, suckling but not adult transgenic mice show enlarged crypts and thus more crypt fissions caused by a transient increase of the crypt transit-amplifying zone. Intestinal enlargement by CD97 requires its seven-span transmembrane/cytoplasmic C-terminal fragment but not the N-terminal fragment binding partner CD55. In summary, ectopic expression of CD97 in intestinal epithelial cells provides a unique model for intestinal cylindrical growth occurring in breast-fed infant